SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1/A
Document Type: EX-FILING FEES
Date Filed: 2024-10-10
Accession Number: 0001213900-24-086889
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390024086889/ea020832411ex-fee_synergy.htm

Chunk 0 of 1
Word Count: 378
Character Count: 2368

Document Content:

Exhibit

Calculation
of Filing Fee Tables

Form

Synergy
CHC Corp.

Table
1: Newly Registered Securities

Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee

Fees to Be Paid Equity Common Stock, par value $0.00001 per share(1)(2) 457(a) 1,150,000 $	11.00 $	12,650,000	(3) 0.00015310 $	1,936.72

Other Representative’s Warrants(4) Other — — — — —

Equity Common Stock issuable upon the exercise of the Representative’s Warrants(5) 457(a) 103,500 $	14.30 $	1,480,050 0.00015310 $	226.60

Fees Previously Paid Equity Common Stock, par value $0.00001 per share(1)(2) 457(a) 2,300,000 $	11.00 $	25,300,000	(3) 0.00014760 $	3,734.28

Other Representative’s Warrants(4) Other — — — — —

Equity Common Stock issuable upon the exercise of the Representative’s Warrants(5) 457(a) 103,500 $	14.30 $	2,960,100 0.00014760 $	436.91

Total Offering Amounts $	14,130,050 — $	2,163.32

Total Fees Previously Paid — — $	4,171.19

Total Fee Offsets — — —

Net Fee Due — — —

(1)	Includes up to an additional
15% of the aggregate offering price to cover a 30-day option granted to the underwriters to purchase additional shares of our common
stock to cover over-allotments, if any.

(2)	Pursuant to Rule 416(a)
of the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock registered hereby also includes
an indeterminable number of additional securities that may be issued to prevent dilution resulting from stock splits, stock dividends
or similar transactions.

(3)	Estimated solely for the
purpose of calculating the registration fee in accordance with Rule 457(a) under the Securities Act of 1933, as amended.

(4)	No fee required pursuant
to Rule 457(g).

(5)	We have agreed to issue
to the representative of the underwriters (the “Representative”), upon the closing of this offering, warrants to purchase
up to an aggregate number of shares of our common stock (the “Representative’s Warrants”) in an aggregate equal
to nine percent (9%) of the aggregate number of shares of common stock to be issued and sold in this offering. The Representative’s
Warrants are exercisable at a per share price equal to 130% of the public offering price per share of the shares of common stock
sold in this offering.